Summary Results of recent clinical trials in patients with stable angina and chronic heart failure have successfully demonstrated a beneficial role of use of ivabradine in addition to the conventional therapy. Based on the results of these trials, the aim of our review was to give an overview of the literature about the use of ivabradine in clinical settings outside its usual purpose
Increased heart rate (HR) is associated with deleterious effects on several disease conditions. Chro...
International audienceIvabradine is an original drug that has been approved in two indications (syst...
Background Ivabradine specifically inhibits the I-f current in the sinoatrial node to lower heart ra...
Coronary artery disease (CAD) and heart failure (HF) are major worldwide threat to health and well-b...
Objective: The objective of this review is to determine whether ivabradine therapy can improve the q...
The Author(s) 2013. This article is published with open access at Springerlink.com Abstract Heart ra...
This article provides an overview of the therapeutic effects of ivabradine in the treatment of coron...
Ivabradine is a unique agent that is distinct from beta-blockers and calcium channel blockers as it ...
Stable angina pectoris affects 2–4 % of the population in Western countries and entails an annual ri...
In chronic stable angina, elevated heart rate contributes to the development of symptoms and signs o...
INTRODUCTION: Ivabradine is a new heart-rate-lowering drug; the aim of this review was to analyze it...
Heart rate reduction is an integral part of antianginal therapy. In this article, we examine current...
Background: Although there are established drugs for treatment of cardiovascular diseases, due to ad...
Abstract Background Coronary artery disease and heart failure are both highly prevalent diseases wit...
Background: Heart rate is the important key factor for determining the cardiac output, myocardial ox...
Increased heart rate (HR) is associated with deleterious effects on several disease conditions. Chro...
International audienceIvabradine is an original drug that has been approved in two indications (syst...
Background Ivabradine specifically inhibits the I-f current in the sinoatrial node to lower heart ra...
Coronary artery disease (CAD) and heart failure (HF) are major worldwide threat to health and well-b...
Objective: The objective of this review is to determine whether ivabradine therapy can improve the q...
The Author(s) 2013. This article is published with open access at Springerlink.com Abstract Heart ra...
This article provides an overview of the therapeutic effects of ivabradine in the treatment of coron...
Ivabradine is a unique agent that is distinct from beta-blockers and calcium channel blockers as it ...
Stable angina pectoris affects 2–4 % of the population in Western countries and entails an annual ri...
In chronic stable angina, elevated heart rate contributes to the development of symptoms and signs o...
INTRODUCTION: Ivabradine is a new heart-rate-lowering drug; the aim of this review was to analyze it...
Heart rate reduction is an integral part of antianginal therapy. In this article, we examine current...
Background: Although there are established drugs for treatment of cardiovascular diseases, due to ad...
Abstract Background Coronary artery disease and heart failure are both highly prevalent diseases wit...
Background: Heart rate is the important key factor for determining the cardiac output, myocardial ox...
Increased heart rate (HR) is associated with deleterious effects on several disease conditions. Chro...
International audienceIvabradine is an original drug that has been approved in two indications (syst...
Background Ivabradine specifically inhibits the I-f current in the sinoatrial node to lower heart ra...